Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological wellbeing in moderate to highly-stressed subjects

Agro Food Industry Hi-Tech

Volumn 21, Issue 1, 2010, Pages 21-24

  Talbott, Shawn ^a   Talboh, Julie ^a  

^a GLH Nutrition Inc   (United States)

Author keywords

1,3 1,6 glucan; glucan; Dietary supplements; Respiratory tract infections; Stress; Yeast glucan

Indexed keywords

DESIGN STUDIES; MEAN AGES; PROFILE OF MOOD STATE; PSYCHOLOGICAL WELL-BEING; RESPIRATORY TRACT INFECTIONS; TREATMENT GROUP; UPPER RESPIRATORY TRACT;

DIETARY SUPPLEMENTS; FOOD ADDITIVES; NUTRITION; STRESSES; YEAST;

VITAMINS;

EID: 77950615734     PISSN: 17226996     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. G.E. Miller, J.J. Treanor et al., Psychosom Med., 44, pp. 215-223 (2004).
2. S. Cohen, G.E. Miller et al., JAMA. 298, pp. 1685-1687(2007).
3. S. Cohen, J.M. Gwaltney et al., Health Psychol.. 17, pp. 214-223 (1998).
4. N.M. Graham, P. Ryan et al.. Am J Epidemiol.. 124, pp. 389-401 (1986).
5. J.M. Cobb, A. Steptoe, Psychosom Med.. 58, pp. 404-412 (1996).
6. R. Glaser, W.B. Malarkey et al.. Arch Gen Psychiatry. 56, pp. 450-456(1999).
7. S. Cohen , D.P. Skoner et al., Psychosom Med., 61, pp. 175-180 (1999).
8. Turner RB, Gangemi JD et al., N Engl J Med, 353.341-348 (2005).
9. S. Sasazuki, S. Tsugane et al., Eur J Clin Nutr., 40, pp. 9-17 (2006).
10. S.M. Van, P. Josling, Adv Ther.. 19, pp. 151-159 (2002).
11. G.N. Predy, T.K. Basu et al., E CMAJ, 73, pp. 1043-1048 (2005).
12. S.N. Meydani, B.C. Fine et al., JAMA, 292, pp. 828-836 (2004).
13. J.M. Graat, F.J. Kok et al., JAMA. 288, pp. 715-721 (2002).
14. G.A. Eby. W.W. Halcomb, Altern Ther Health Med.,12, pp. 34-38 (2006).
15. S. Talbot, J. Talbot, J Sports Sci Med.. 8:509-515 (2009).
16. S. Feldman, D.R. Krieger et al., J Appl Res, 9, pp. 30-42 (2009).
17. A. Bedirli, H. Pasaoglu et al.. Shock, 27, pp. 397-401 (2007).
18. N. Ikewaki, H. Inoko et al., Microbiol. Immunol., 51, pp. 861-873 (2007).
19. J. Liang, L. Cafro et al.. Int J lmmunopharmacol., 20, pp. 595-614(1998).
20. V. Vetvicka, G. Ostroff et al., J Am Neutraceut Assoc, 5, pp. 5-9 (2002).
21. D.S. Kernodle, A.B. Kaiser et al., Antimicrob Agents Chemother, 42, pp. 545-549 (1998).
22. S.M.Talbott, C. Ekberg et al.,Faseb J.21, 111.1A (2007).
23. S.M. Talbott, C Ekberg et al.. Med Sci Sports Exerc, 39, S227 (2007).
24. D. McNair, E. Shilony et al., Profile of Mood States Bibliography 1964-2002, Multi-Health Systems: North Tonawanda, NY (2003).
25. D.M. McNair, M. Lorr et al., EdlTS Manual for the Profile of Mood States, Educational and Industrial Testing Service, San Diego, CA (1992).
26. A. Strasner, A. Dunn et al.. Med Sci Sports Exerc, 33, S301 (2001).
27. S. Cohen, A.P. Smith et al., N Engl J Med., 325, pp. 606-612 (1991).
28. F. Hong, J. Yan et al., J Immunol., 173, pp. 797-806 (2004).
29. M. Driscoll, J. Yan et al.. Cancer Biol Therapy, 8, pp. 216-223 (2009).
30. D.C. Nieman et al.. Med Sci Sports Exerc. 40, pp. 1463-1471 (2008).